Interstitial lung disease
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Interstitial lung disease Classification and external resources | |
 | |
|---|---|
| End-stage pulmonary fibrosis of unknown origin, taken from an autopsy | |
| ICD-10 | J84.9 |
| ICD-9 | 506.4, 508.1, 515, 516.3, 714.81, 770.7 |
| DiseasesDB | 31509 |
| eMedicine | ped/1950 |
| MeSH | D017563 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Introduction
Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases (including idiopathic pulmonary fibrosis), affecting the alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues. The term ILD is used to distinguish these diseases from obstructive airways diseases. Most types of ILD involve fibrosis, but this is not essential; indeed fibrosis is often a later feature. Hence the term pulmonary fibrosis has fallen out of favor.
Causes
ILD may be classified according to the cause: -
- Inhaled substances
- Inorganic
- Organic
- Drug induced
- Connective tissue disease
- Infection
- Atypical pneumonia
- Pneumocystis pneumonia (PCP)
- Tuberculosis
- Idiopathic
- Malignancy
- Lymphangitic carcinomatosis
Investigation
Investigation is tailored towards the symptoms and signs. Most patients have blood testing, chest x-ray, pulmonary function testing, and high resolution CT thorax.
Treatment
ILD is not a single disease, but encompasses many different pathological processes. Hence treatment is different for each disease.
If a specific occupational exposure cause is found, the person should avoid that environment. If a drug cause is suspected, that drug should be discontinued.
Many idiopathic and connective tissue-based causes of ILD are treated with prednisolone. Some patients respond to immunosuppressant treatment. Patients with hypoxemia may be given supplemental oxygen.
External links
- Coalition for Pulmonary Fibrosis - Research, Education, Support & Hope
- What is Pulmonary Fibrosis?
- 00736 at CHORUS
- 1476788304 at GPnotebook
- MeSH Pulmonary+Fibrosis
- MedlinePlus Overview pulmonaryfibrosis
- AIMIP - Italian Association for IPF - Associazione Italiana
- Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases
- University of Chicago Interstitial Lung Disease Program
- PA-IPF - The Pennsylvania Idiopathic Pulmonary Fibrosis State Registry
WikiDoc Research Resources for Interstitial lung disease | |
|---|---|
| Articles on Interstitial lung disease | Most recent articles on Interstitial lung disease • Most cited articles on Interstitial lung disease • Review articles on Interstitial lung disease • Articles on Interstitial lung disease in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Interstitial lung disease | Powerpoint slides on Interstitial lung disease • Images of Interstitial lung disease • Photos of Interstitial lung disease • Podcasts & MP3s on Interstitial lung disease • Videos on Interstitial lung disease |
| Evidence Based Medicine Regarding Interstitial lung disease | Cochrane Collaboration on Interstitial lung disease • Bandolier on Interstitial lung disease • TRIP on Interstitial lung disease |
| Cost Effectiveness of Interstitial lung disease | Cost Effectiveness of Interstitial lung disease |
| Clinical Trials Involving Interstitial lung disease | Ongoing Trials on Interstitial lung disease at Clinical Trials.gov • Trial results on Interstitial lung disease • Clinical Trials on Interstitial lung disease at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Interstitial lung disease | US National Guidelines Clearinghouse on Interstitial lung disease • NICE Guidance on Interstitial lung disease • NHS PRODIGY Guidance • FDA on Interstitial lung disease • CDC on Interstitial lung disease |
| Textbook Information on Interstitial lung disease | Books and Textbook Information on Interstitial lung disease |
| Pharmacology Resources on Interstitial lung disease | Dosing of Interstitial lung disease • Drug interactions with Interstitial lung disease • Side effects of Interstitial lung disease • Allergic reactions to Interstitial lung disease • Overdose information on Interstitial lung disease • Carcinogenicity information on Interstitial lung disease • Interstitial lung disease in pregnancy • Pharmacokinetics of Interstitial lung disease • |
| Genetics, Pharmacogenomics, and Proteinomics of Interstitial lung disease | Genetics of Interstitial lung disease • Pharmacogenomics of Interstitial lung disease • Proteomics of Interstitial lung disease |
| Newstories on Interstitial lung disease | Interstitial lung disease in the news • Be alerted to news on Interstitial lung disease • News trends on Interstitial lung disease |
| Commentary on Interstitial lung disease | Blogs on Interstitial lung disease |
| Patient Resources on Interstitial lung disease | Patient resources on Interstitial lung disease • Discussion groups on Interstitial lung disease • Patient Handouts on Interstitial lung disease • Directions to Hospitals Treating Interstitial lung disease • Risk calculators and risk factors for Interstitial lung disease |
| Healthcare Provider Resources on Interstitial lung disease | Symptoms of Interstitial lung disease • Causes & Risk Factors for Interstitial lung disease • Diagnostic studies for Interstitial lung disease • Treatment of Interstitial lung disease |
| Continuing Medical Education (CME) Programs on Interstitial lung disease | CME Programs on Interstitial lung disease |
| International Resources on Interstitial lung disease | Interstitial lung disease en Espanol • Interstitial lung disease en Francais |
| Business Resources on Interstitial lung disease | Interstitial lung disease in the Marketplace • Patents on Interstitial lung disease |
| Informatics Resources on Interstitial lung disease | List of terms related to Interstitial lung disease |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
